Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Expands By 72.0%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 62,100 shares, a growth of 72.0% from the February 28th total of 36,100 shares. Based on an average daily volume of 1,440,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.2% of the shares of the stock are sold short.

Biodexa Pharmaceuticals Stock Performance

Shares of BDRX stock opened at $1.23 on Friday. Biodexa Pharmaceuticals has a fifty-two week low of $1.23 and a fifty-two week high of $74.00. The company has a fifty day moving average price of $3.39.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.